New autism committee chair has financial ties to leucovorin, raising conflict-of-interest concerns

RFK Jr. appointed pediatric neurologist John Gaitanis to chair the Interagency Autism Coordinating Committee, which guides ~$2B in federal autism research funding. Gaitanis has financial ties to leucovorin, a treatment he has promoted for autism, raising conflict-of-interest concerns. The appointment signals a shift in federal autism research priorities under the current administration.